Sobin Chang, MPH

Chief Executive Officer

Over 20 years of experience in Management, Marketing, and Research in pharmaceuticals, devices, biologics as well as nutraceuticals from recognized brand BOTOX® to $7.5B oncology portfolio. She built her corporate track record with Pfizer, Bayer, Schering-Plough (Merck), Novartis and Allergan. Her breadth of experience in various therapeutic areas includes neuroscience, dermatology, infectious disease, allergy & immunology and oncology, which lead to over 20 inventions. She is a trained pharmacoeconomist and has over 60 publications. She was recently the opening keynote speaker for Big data in Pharma conference in Philadelphia. She served at the US Department of Health and Human Services, the Division of Drug Marketing, Advertising and Communications of the Food and Drug Administration (FDA DDMAC) providing guidance on the FDA Modernization Act. Sobin received her B.A. Honors in Mathematics with Magna Cum Laude from University of Missouri-Columbia, a Master of Public Health Degree (MPH) and post-doctoral fellowship in Biostatistics, Regulatory Affairs and Pharmacoeconomics from Yale School of Medicine. She is currently serving as a Director of the Board at AYAPH (Association of Yale Alumni in Public Health) and Chair, Business and Industry Committee.


©2010-2020 by Aquavit Pharmaceuticals, Inc. Privacy and Terms.